STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
32 hedge funds and large institutions have $94.2M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$970K | |
| 2 | +$617K | |
| 3 | +$242K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$195K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$69K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$457K | |
| 3 | -$311K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$263K |
| 5 |
Two Sigma Investments
New York
|
-$156K |